Skip to main content

Table 1 Epidemiological and clinical findings

From: Idiopathic intracranial hypertension in pediatric and adolescent patients

  Total Group I Group II P value
Age (in years) 9.7 ± 4.4 (4–15) 5.56 ± 1.9 (4–9) 13.5 ± 1.3 (12–15) < 0.001
Gender (F/M) 16/19 (84.2%) 6 /9 (66.7%) 10/10 (100%) 0.04
Follow-up (in months) 12 ± 8.6 (4–36) 12.1 ± 10.6(6–36) 11.8 ± 6.7(4–24) 0.9
Recurrence 4/19 (21%) 1/9 (11.1%) 3/10 (30%) 0.3
Clinical findings
 Sixth nerve palsy 4/19 (21%) 4/9 (44.4%) 0/10 (0%) 0.018
 Headache 12/19 (63.2%) 4/9 (44.4%) 8/10 (80%) 0.03
 Blurring of vision 8/19 (42.1%) 3/9 (33.3%) 5/10 (50%) 0.4
 Visual obscurations 5/19 (26.3%) 1/9 (11.1%) 4/10 (40%) 0.16
 Deterioration of the school performance 12/19 (63.16%) 4/9 (44.4%) 8/10 (80%) 0.1
 Irritability and irregular sleep 8/19 (42.1%) 5/9 (55.5%) 3/10 (30%) 0.27
 ICP (mmH2O) 291 ± 79.5 (180–460) 258 ± 69 (180–350) 320 ± 80 (250–460) 0.09